359 related articles for article (PubMed ID: 25341940)
1. Curcumin in combined cancer therapy.
Troselj KG; Kujundzic RN
Curr Pharm Des; 2014; 20(42):6682-96. PubMed ID: 25341940
[TBL] [Abstract][Full Text] [Related]
2. The use of curcumin as an effective adjuvant to cancer therapy: A short review.
Bashang H; Tamma S
Biotechnol Appl Biochem; 2020 Mar; 67(2):171-179. PubMed ID: 31608504
[TBL] [Abstract][Full Text] [Related]
3. Curcumin attenuates allergic airway inflammation and hyper-responsiveness in mice through NF-κB inhibition.
Oh SW; Cha JY; Jung JE; Chang BC; Kwon HJ; Lee BR; Kim DY
J Ethnopharmacol; 2011 Jul; 136(3):414-21. PubMed ID: 20643202
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel compound (β-sesquiphellandrene) from turmeric (Curcuma longa) with anticancer potential: comparison with curcumin.
Tyagi AK; Prasad S; Yuan W; Li S; Aggarwal BB
Invest New Drugs; 2015 Dec; 33(6):1175-86. PubMed ID: 26521943
[TBL] [Abstract][Full Text] [Related]
5. Curcumin and Cancer.
Giordano A; Tommonaro G
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31590362
[TBL] [Abstract][Full Text] [Related]
6. Curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves downregulation of nuclear endonuclease G and NF-κB as well as induction of apoptosis and G2/M arrest.
Wang YT; Liu HS; Su CL
Int J Food Sci Nutr; 2014 May; 65(3):368-74. PubMed ID: 24438326
[TBL] [Abstract][Full Text] [Related]
7. Curcumin inhibits autocrine growth hormone-mediated invasion and metastasis by targeting NF-κB signaling and polyamine metabolism in breast cancer cells.
Coker-Gurkan A; Celik M; Ugur M; Arisan ED; Obakan-Yerlikaya P; Durdu ZB; Palavan-Unsal N
Amino Acids; 2018 Aug; 50(8):1045-1069. PubMed ID: 29770869
[TBL] [Abstract][Full Text] [Related]
8. Curcumin inhibits cell proliferation and promotes apoptosis in human osteoclastoma cell through MMP-9, NF-κB and JNK signaling pathways.
Cao F; Liu T; Xu Y; Xu D; Feng S
Int J Clin Exp Pathol; 2015; 8(6):6037-45. PubMed ID: 26261481
[TBL] [Abstract][Full Text] [Related]
9. Curcumin suppresses the TPA-induced invasion through inhibition of PKCα-dependent MMP-expression in MCF-7 human breast cancer cells.
Kim JM; Noh EM; Kwon KB; Kim JS; You YO; Hwang JK; Hwang BM; Kim BS; Lee SH; Lee SJ; Jung SH; Youn HJ; Lee YR
Phytomedicine; 2012 Sep; 19(12):1085-92. PubMed ID: 22921746
[TBL] [Abstract][Full Text] [Related]
10. Anticancer potential of curcumin: preclinical and clinical studies.
Aggarwal BB; Kumar A; Bharti AC
Anticancer Res; 2003; 23(1A):363-98. PubMed ID: 12680238
[TBL] [Abstract][Full Text] [Related]
11. Curcumin: New Insights into an Ancient Ingredient against Cancer.
Willenbacher E; Khan SZ; Mujica SCA; Trapani D; Hussain S; Wolf D; Willenbacher W; Spizzo G; Seeber A
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013694
[TBL] [Abstract][Full Text] [Related]
12. Prospective of curcumin, a pleiotropic signalling molecule from Curcuma longa in the treatment of Glioblastoma.
Luthra PM; Lal N
Eur J Med Chem; 2016 Feb; 109():23-35. PubMed ID: 26748069
[TBL] [Abstract][Full Text] [Related]
13. Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression.
Chen J; Wang FL; Chen WD
Mol Biol Rep; 2014 Jul; 41(7):4583-94. PubMed ID: 24604727
[TBL] [Abstract][Full Text] [Related]
14. Curcumin: the Indian solid gold.
Aggarwal BB; Sundaram C; Malani N; Ichikawa H
Adv Exp Med Biol; 2007; 595():1-75. PubMed ID: 17569205
[TBL] [Abstract][Full Text] [Related]
15. Curcumin's Beneficial Effects on Neuroblastoma: Mechanisms, Challenges, and Potential Solutions.
Zhai K; Brockmüller A; Kubatka P; Shakibaei M; Büsselberg D
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33105719
[TBL] [Abstract][Full Text] [Related]
16. Curcumin: from ancient medicine to current clinical trials.
Hatcher H; Planalp R; Cho J; Torti FM; Torti SV
Cell Mol Life Sci; 2008 Jun; 65(11):1631-52. PubMed ID: 18324353
[TBL] [Abstract][Full Text] [Related]
17. Curcumin attenuates lipopolysaccharide-induced renal inflammation.
Zhong F; Chen H; Han L; Jin Y; Wang W
Biol Pharm Bull; 2011; 34(2):226-32. PubMed ID: 21415532
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria as a target in the therapeutic properties of curcumin.
Trujillo J; Granados-Castro LF; Zazueta C; Andérica-Romero AC; Chirino YI; Pedraza-Chaverrí J
Arch Pharm (Weinheim); 2014 Dec; 347(12):873-84. PubMed ID: 25243820
[TBL] [Abstract][Full Text] [Related]
19. Anti-Angiogenic Activity of Curcumin in Cancer Therapy: A Narrative Review.
Shakeri A; Ward N; Panahi Y; Sahebkar A
Curr Vasc Pharmacol; 2019; 17(3):262-269. PubMed ID: 29424316
[TBL] [Abstract][Full Text] [Related]
20. Curcumin: a promising agent targeting cancer stem cells.
Zang S; Liu T; Shi J; Qiao L
Anticancer Agents Med Chem; 2014; 14(6):787-92. PubMed ID: 24851881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
